BIOMAT Database Logo BIOMAT Database Logo

Pentose-phosphate pathway of leucocytes. 1971

T Markkanen, and O Peltola

UI MeSH Term Description Entries
D007945 Leukemia, Lymphoid Leukemia associated with HYPERPLASIA of the lymphoid tissues and increased numbers of circulating malignant LYMPHOCYTES and lymphoblasts. Leukemia, Lymphocytic,Lymphocytic Leukemia,Lymphoid Leukemia,Leukemias, Lymphocytic,Leukemias, Lymphoid,Lymphocytic Leukemias,Lymphoid Leukemias
D007962 Leukocytes White blood cells. These include granular leukocytes (BASOPHILS; EOSINOPHILS; and NEUTROPHILS) as well as non-granular leukocytes (LYMPHOCYTES and MONOCYTES). Blood Cells, White,Blood Corpuscles, White,White Blood Cells,White Blood Corpuscles,Blood Cell, White,Blood Corpuscle, White,Corpuscle, White Blood,Corpuscles, White Blood,Leukocyte,White Blood Cell,White Blood Corpuscle
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009101 Multiple Myeloma A malignancy of mature PLASMA CELLS engaging in monoclonal immunoglobulin production. It is characterized by hyperglobulinemia, excess Bence-Jones proteins (free monoclonal IMMUNOGLOBULIN LIGHT CHAINS) in the urine, skeletal destruction, bone pain, and fractures. Other features include ANEMIA; HYPERCALCEMIA; and RENAL INSUFFICIENCY. Myeloma, Plasma-Cell,Kahler Disease,Myeloma, Multiple,Myeloma-Multiple,Myelomatosis,Plasma Cell Myeloma,Cell Myeloma, Plasma,Cell Myelomas, Plasma,Disease, Kahler,Multiple Myelomas,Myeloma Multiple,Myeloma, Plasma Cell,Myeloma-Multiples,Myelomas, Multiple,Myelomas, Plasma Cell,Myelomas, Plasma-Cell,Myelomatoses,Plasma Cell Myelomas,Plasma-Cell Myeloma,Plasma-Cell Myelomas
D010428 Pentosephosphates
D010672 Phenytoin An anticonvulsant that is used to treat a wide variety of seizures. It is also an anti-arrhythmic and a muscle relaxant. The mechanism of therapeutic action is not clear, although several cellular actions have been described including effects on ion channels, active transport, and general membrane stabilization. The mechanism of its muscle relaxant effect appears to involve a reduction in the sensitivity of muscle spindles to stretch. Phenytoin has been proposed for several other therapeutic uses, but its use has been limited by its many adverse effects and interactions with other drugs. Diphenylhydantoin,Fenitoin,Phenhydan,5,5-Diphenylhydantoin,5,5-diphenylimidazolidine-2,4-dione,Antisacer,Difenin,Dihydan,Dilantin,Epamin,Epanutin,Hydantol,Phenytoin Sodium,Sodium Diphenylhydantoinate,Diphenylhydantoinate, Sodium
D003920 Diabetes Mellitus A heterogeneous group of disorders characterized by HYPERGLYCEMIA and GLUCOSE INTOLERANCE.
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

T Markkanen, and O Peltola
[Pentose phosphate pathway].
March 1997, Nihon rinsho. Japanese journal of clinical medicine,
T Markkanen, and O Peltola
The pentose phosphate pathway.
December 2002, The Journal of biological chemistry,
T Markkanen, and O Peltola
Enzymes of the pentose phosphate pathway.
January 1961, Methods in medical research,
T Markkanen, and O Peltola
Pentose phosphate pathway mutants of yeast.
January 1982, Molecular & general genetics : MGG,
T Markkanen, and O Peltola
Pentose phosphate pathway drives vascular maturation.
January 2022, Nature metabolism,
T Markkanen, and O Peltola
The pentose phosphate pathway and cancer.
August 2014, Trends in biochemical sciences,
T Markkanen, and O Peltola
Pentose phosphate pathway and radiation disease.
January 1979, Acta Universitatis Carolinae. Medica. Monographia,
T Markkanen, and O Peltola
Physiological functions of the pentose phosphate pathway.
October 1986, Cell biochemistry and function,
T Markkanen, and O Peltola
Queueing theory model of pentose phosphate pathway.
March 2022, Scientific reports,
T Markkanen, and O Peltola
Effect of inorganic phosphate on erythrocyte pentose phosphate pathway activity.
January 1972, Biochimica et biophysica acta,
Copied contents to your clipboard!